Online
Clinical Case Study (June 2005)
Clinical
Cardiology Series
臨床心臟科個案研究
The
content of the Office Cardiology Series is provided by:
Dr. Li Siu Lung, Steven
M.B.,B.S.(H.K.),
M.R.C.P.(U.K.), F.H.K.A.M., F.H.K.C.P., F.R.C.P.(Glasg.), F.R.C.P.(Edin.), Specialist
in Cardiology
Dr.
Wong Shou Pang, Alexander
F.R.C.P.,
F.H.K.A.M.(Med.), F.H.K.C.P., Specialist in Cardiology
臨床心臟科個案研究之內容誠蒙李少隆醫生及王壽鵬醫生提供。
Highlights from
late breaking clinical trials from the American College of Cardiology 2005 Annual
Scientific Session
What do you think
about these hypotheses? Please indicate true or false to the following statements
with supporting explanation.
Answers
| 1. |
A regimen of calcium channel blocker with or without an angiotensin-converting
enzyme inhibitor (ACEI) is more effective than an older regimen of beta-blocker
with or without a diuretic in terms of blood pressure control and reduction
of coronary heart disease events in hypertensive patients with relatively
low cholesterol levels.
|
|
True. This
hypothesis was proven in the Anglo-Scandinavian Cardiac Outcomes Trial
(ASCOT). Amlodipine and perindopril were used against atenolol and bendroflumethiazide.
The trial was discontinued early because of the efficacy of the amlodipine/perindopril
arm. In this arm, several prespecified secondary endpoints were significantly
lower, including all-cause mortality, all coronary events, all cardiovascular
events and procedures, stroke and cardiovascular mortality when compared
with the beta-blocker arm. New onset diabetes was also lower in this treatment
arm.
|
| |
Back
to top
|
| 2. |
Among patients with stable coronary heart disease, a LDL target of 75mg/dl
will reduce more cardiovascular events when compared with a target of
100mg/dl.
|
|
True. This
was proven in the Treating to New Targets Study (TNT). Among patients
with stable ischemic heart disease, treatment with high dose (80mg) atorvastatin
to achieve an LDL below 100mg/dl was associated with a reduction in the
primary endpoint of major cardiovascular events at 5 years including non-fatal
myocardial infarction and stroke when compared with treatment with low
dose (10mg). Among the secondary endpoints, major coronary events and
hospitalization for congestive heart failure was also lowered in the aggressive
treatment arm. However, persistent abnormal liver function tests were
more frequent in the 80mg group compared with the 10mg group, indicating
that close monitoring is necessary in patients receiving this high dose.
|
| |
Back
to top
|
| 3. |
COX-2 inhibitors are safe for pain management following coronary artery
bypass grafting surgery.
|
|
False. In
the COX-2 inhibitors After Cardiac Surgery trial, among patients undergoing
CABG with cardiopulmonary bypass, short term treatment with COX-2 inhibitor
for pain management was associated with an increase in overall adverse
events and in cardiovascular adverse events. It should also be noted that
in other recent trials in patients receiving other selective COX-2 inhibitors
for the prevention of colorectal cancer, a higher incidence of serious
arterial thromboembolic events was also noted, raising the concerns on
the safety of this group of drugs in patients with cardiovascular disease.
|
| |
Back
to top
|
| 4. |
Treatment with vitamin E as compared with placebo is associated with a
reduction in primary cardiovascular events in women.
|
|
False. In
the Women's Health Study: Vitamin E in Primary Prevention, treatment with
600 IU on alternate days was not associated with a difference in the primary
endpoint of major cardiovascular event reduction at a mean 10 year follow
up when compared with placebo. These findings, along with data from the
earlier Heart Protection Study, do not support the use of vitamin E for
prevention of cardiovascular disease.
|
| |
Back
to top
|
Dermatology
Series 皮膚科病例研究
A 10 year old Chinese
girl was noticed by her mother to have increased hair loss and bald patches
on the scalp for six months. She was asymptomatic except for minimal itch. She
enjoyed good general health with no history of significant medical illness.
There was no family history of baldness. She worked very hard with her school
work. Recent topical treatment given by her family doctor produced no improvement.
Physical examination revealed a large triangular shaped partial alopecia over
her right parietal and vertex areas. The frontal scalp hair was unaffected.
Examination of other hair bearing areas was normal.
 |
The
content of the Dermatology Series is provided by:
Dr. Tang Yuk Ming, William and Dr. Chan Loi Yuen
Specialist in Dermatology & Venereology
皮膚科病例研究之內容誠蒙鄧旭明醫生及陳來源醫生提供。 |
Answers
| 1. |
What
are the clinical differential diagnoses?
|
|
The clinical
differential diagnoses are alopecia areata, tinea capitis and trichotillomania.
Trichotillomania (compulsive hair pulling) is a neurotic practice of plucking
one's own hair from the scalp or eyelashes, usually as a mechanism to
relieve stress or tension.
|
| |
Back
to top
|
| 2. |
What
bedside examination should be performed?
|
|
The scalp
should be examined for "exclamation mark hair" which was characteristic
of active alopecia areata. A Wood's lamp examination helps to detect the
fluorescence of tinea capitis caused by some fungi such as Microsporum
canis. Microscopic examination of hair sample for fungal elements should
also be performed as appropriate. These examinations were negative in
this patient. A "hair growth window" test will help to diagnose
trichotillomania: shave a 3x3 cm2 area in the involved part
of the scalp weekly. Hair inside this area will be too short for plucking
and the hair will recover and regain normal density several weeks later.
|
| |
Back
to top
|
| 3. |
What
are the characteristic features of scalp hair seen in this condition?
|
|
Focal bizarre
patches of alopecia on scalp of dominant hand side with remaining short
stubby broken hair are features of trichotillomania.
|
| |
Back
to top
|
| 4. |
Name
one complication that may be seen in this condition.
|
|
Gastric trichobezoar
due to ingestion of the pulled hair may be seen in some cases. If severe,
it may produce intestinal obstruction.
|
| |
Back
to top
|
| 5. |
What
is the definite treatment?
|
|
The impulsive
reactive nature of this condition should be explained and reassurance
given to the patient and parents. In mild acute cases, the condition can
be self limiting. In chronic cases, psychiatrist assessment with behavioral
modification, psychotherapy and use of selective serotonin reuptake inhibitor
may be required.
|
| |
Back
to top
|
Back
to Online Clinical Case Study